ZIMMERMANN MARTINE received a stock award from LIGAND PHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/10/2025ACC: 0002001011-25-000043
Director
Since Sep 2023
+6.80K
Net shares
Net buyer
$19.9K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
6.99K acquired · 188.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.21K
Price / share
—
Trade value
—
% of position
34.2%
6/6/2025
3.54K→4.75K
Common Stock
Direct
Shares
−188.00
Price / share
$105.99
Trade value
$19.93K
% of position
4.0%
6/6/2025
4.75K→4.56K
Total
Net shares
+1.02K
Net value
-$19.93K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/6/2025 | A · Award | +1.21K | — | — | 34.2% | 3.54K | 4.75K |
| Common Stock Direct | 6/6/2025 | F · Tax Withholding | −188.00 | $105.99 | $19.93K | 4.0% | 4.75K | 4.56K |
| Total | +1.02K | -$19.93K | ||||||
Derivative Transactions1
Non-Qualified Stock Option (right to buy)
Direct
Converts to
Common Stock
5.78K shares
Shares
+5.78K
Strike price
105.99
Held after
5.78K
Exercisable
—
6/6/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) Direct | Common Stock5.78K shares | 6/6/2025 | A · Award | +5.78K | 105.99 | — | 5.78K |